20% with cancer on checkpoint inhibitors get thyroid dysfunctionApril 2, 2020OncologyBreast CancerLung Cancer
No staff COVID-19 diagnoses after plan at Chinese cancer centerApril 2, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerLung CancerMelanomaOncology
Maintaining cancer care in the face of COVID-19April 1, 2020COVID-19 UpdatesGenitourinary CancerLung CancerMultiple MyelomaMelanomaInfectious DiseasesOncology
Blood test might detect multiple cancer types, study suggestsMarch 31, 2020OncologyMixed TopicsLung CancerGenitourinary Cancer
Guidelines on delaying cancer surgery during COVID-19March 26, 2020COVID-19 UpdatesBreast CancerLung CancerOncology
Cancer care and COVID-19 in Seattle, the first U.S. epicenterMarch 23, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerLung CancerMelanomaOncology
How is oncology adapting to COVID-19?March 23, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerLung CancerMelanoma
Disruptions in cancer care in the era of COVID-19March 20, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerLung CancerMelanomaOncology
Best definition of malnutrition varies by cancer typeMarch 6, 2020Genitourinary CancerLung CancerMixed TopicsOncology
Pembro ups survival in NSCLC: ‘Really extraordinary’ resultsMarch 3, 2020Lung CancerOncologyPulmonology
Glaring gap in CV event reporting in pivotal cancer trialsFebruary 12, 2020Mixed TopicsCardiologyBreast CancerOncologyLung Cancer
Walk test may predict complications after lung cancer surgeryFebruary 3, 2020Lung CancerCardiologyOncology
Lenvatinib/pembrolizumab has good activity in advanced RCC, other solid tumorsJanuary 31, 2020Immuno-oncologyGenitourinary CancerMelanomaLung CancerOncology
